Research output per year
Research output per year
Fingerprint
Dive into the research topics where Claudia Bighin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
Schettini, F., Conte, B., Buono, G., De Placido, P., Parola, S., Griguolo, G., Fabi, A., Bighin, C., Riccardi, F., Cianniello, D., De Laurentiis, M., Puglisi, F., Pelizzari, G., Bonotto, M., Russo, S., Frassoldati, A., Pazzola, A., Montemurro, F., Lambertini, M., Guarneri, V. & 8 others, , Apr 1 2021, In: ESMO Open. 6, 2, p. 100099 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study: ESMO open
Blondeaux, E., Ferreira, A. R., Poggio, F., Puglisi, F., Bighin, C., Sottotetti, F., Montemurro, F., Poletto, E., Lai, A., Sini, V., Minuti, G., Mura, S., Fontana, A., Fregatti, P., Cardinali, B., Lambertini, M. & Del Mastro, L., 2020, In: ESMO Open. 5, 4, 9 p., e000719.Research output: Contribution to journal › Article › peer-review
-
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study
Blondeaux, E., Ferreira, A. R., Poggio, F., Puglisi, F., Bighin, C., Sottotetti, F., Montemurro, F., Poletto, E., Lai, A., Sini, V., Minuti, G., Mura, S., Fontana, A., Fregatti, P., Cardinali, B., Lambertini, M. & Del Mastro, L., Aug 1 2020, In: ESMO Open. 5, 4Research output: Contribution to journal › Article › peer-review
Open Access -
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
Blondeaux, E., Lambertini, M., Michelotti, A., Conte, B., Benasso, M., Dellepiane, C., Bighin, C., Pastorino, S., Levaggi, A., Alonzo, A. D., Poggio, F., Buzzatti, G., Molinelli, C., Fregatti, P., Bertoglio, S., Boccardo, F. & Del Mastro, L., Jan 1 2020, (Accepted/In press) In: British Journal of Cancer.Research output: Contribution to journal › Article › peer-review
-
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial: International Journal of Cancer
Lambertini, M., Poggio, F., Bruzzone, M., Conte, B., Bighin, C., de Azambuja, E., Giuliano, M., De Laurentiis, M., Cognetti, F., Fabi, A., Bisagni, G., Durando, A., Turletti, A., Urracci, Y., Garrone, O., Puglisi, F., Montemurro, F., Ceppi, M. & Del Mastro, L., 2020, In: Int. J. Cancer. 147, 1, p. 160-169 10 p.Research output: Contribution to journal › Article › peer-review